Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 11Neoplasms 4Stomach Neoplasms 2Small Cell Lung Carcinoma 2Metastatic Pancreatic Adenocarcinoma 2Colorectal Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor 1Refractory Solid Tumors 1Pancreatic cancer, adult 1Pancreatic Diseases 1Pancreatic Cancer Non-resectable 1Ovarian Neoplasms 1Neoplasm Metastasis 1Metastatic Adenocarcinoma of the Pancreas 1Malignant Tumor of Pancreas Metastatic to Liver 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Endocrine Gland Neoplasms 1Digestive System Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Pancreatic Ductal 1Carcinoma, Islet Cell 1Biliary Tract Neoplasms 1Advanced Solid Tumors 1Advanced Pancreatic Cancer 1Advanced Esophageal Squamous Cell Cancer 1Advanced Breast Cancer 1Adenoma, Islet Cell 1

Interventions

Gemcitabine 12Cisplatin 10pembrolizumab 7Fluorouracil 7Leucovorin 6Oxaliplatin 5durvalumab 3Capecitabine 3zanidatamab 2Paclitaxel 2Irinotecan 2Folfox protocol 2Bevacizumab 2vandetanib 1tucatinib 1trastuzumab deruxtecan 1seribantumab 1merestinib 1lenvatinib 1irinotecan sucrosofate 1galactomannan 1fludarabine 1exatecan 1bintrafusp alfa protein, human 1becatecarin 1aldesleukin 1Trastuzumab 1Temozolomide 1Tegafur 1S 1 (combination) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Gallbladder Neoplasms × irinotecan sucrosofate × Clear all
NCT05009953 2024-07-11

Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer

CSPC Ouyi Pharmaceutical Co., Ltd.

Phase 2 Terminated
17 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡